Article

Warp Sciences exits stealth with $215 million to use robotics for drug discovery

Warp Sciences exited stealth last week with $215 million in funding and plans to build a chemistry contract research organization (CRO) in the United States, combining chemists, robots, and AI to synthesize and test molecules for research teams.

Part of the event: Warp Sciences Emerges from Stealth with $215 Million in Funding

This page provides a summary and source link only.